Overview Randomized Trial of Adult Subjects With Generalized Anxiety Disorder Status: Completed Trial end date: 2020-05-08 Target enrollment: Participant gender: Summary The purpose of this study is to compare the efficacy of BHV-4157 versus placebo in subjects with Generalized Anxiety Disorder. Phase: Phase 3 Details Lead Sponsor: Biohaven Pharmaceuticals, Inc.